|
CVG
|
CSPC Pharmaceutical Group Limited
|
DE
|
F
|
|
ENM
|
CASI PHARMAC. NEW O.N.
|
DE
|
F
|
|
F6T
|
Fate Therapeutics Inc
|
DE
|
F
|
|
GE9
|
Genmab A/S
|
DE
|
F
|
|
GE91
|
GENMAB AS SP.ADR/1/10DK 1
|
DE
|
F
|
|
GXE
|
Galapagos NV
|
DE
|
F
|
|
GXEA
|
Galapagos NV
|
DE
|
F
|
|
LGDN
|
Ligand Pharmaceuticals Incorporated
|
DE
|
F
|
|
OND
|
Oncopeptides AB (publ)
|
DE
|
F
|
|
RV7
|
Halozyme Therapeutics Inc
|
DE
|
F
|
|
YP2A
|
BioLineRx Ltd
|
DE
|
F
|
|
ZVA
|
Cellectis S.A
|
DE
|
F
|
|
ZVAA
|
Cellectis S.A
|
DE
|
F
|
|
AOV
|
Amotiv Limited
|
CA
|
TO
|
|
08HH
|
Shanghai Fosun Pharmaceutical (Group) Co. Ltd
|
DE
|
STU
|
|
TELO
|
Telo Genomics Corp
|
CA
|
V
|
|
VXL
|
Vaxil Bio Ltd
|
CA
|
V
|
|
WAVE
|
Waverley Pharma Inc
|
CA
|
V
|
|
GLENMARK
|
Glenmark Pharmaceuticals Limited
|
IN
|
NSE
|
|
0MGB
|
Genmab
|
GB
|
LSE
|